| Literature DB >> 12892015 |
R A de Moor1, L Mourad, J ter Haar, A C Egberts.
Abstract
Withdrawal symptoms occurred in a male neonate after maternal use of venlafaxine for depression during pregnancy. The symptoms were restlessness, hypertonia, jitteriness, irritability and poor feeding. The diagnosis was confirmed by a temporary improvement after administration of a low dose (1 mg) of venlafaxine to the boy. Eventually the symptoms began to decline spontaneously, and ceased after 8 days. Exposure to venlafaxine and other antidepressants which inhibit serotonin reuptake during the third trimester of pregnancy carries the risk of a neonatal withdrawal syndrome.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12892015
Source DB: PubMed Journal: Ned Tijdschr Geneeskd ISSN: 0028-2162